Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study

Binyang Zhao, Shuang Liao, Xuefei Zhong, Yuanyuan Luo, Siqi Hong, Min Cheng, Jie Zhang, Tingsong Li, Li Jiang

Open source

DOI
10.3389/fneur.2022.909191
Published
2022-06-01
Container
Frontiers in Neurology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2022.909191,
  title = {Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study},
  author = {Binyang Zhao and Shuang Liao and Xuefei Zhong and Yuanyuan Luo and Siqi Hong and Min Cheng and Jie Zhang and Tingsong Li and Li Jiang},
  year = {2022},
  journal = {Frontiers in Neurology},
  doi = {10.3389/fneur.2022.909191},
  url = {https://doi.org/10.3389/fneur.2022.909191}
}

RIS

TY  - JOUR
TI  - Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study
AU  - Binyang Zhao
AU  - Shuang Liao
AU  - Xuefei Zhong
AU  - Yuanyuan Luo
AU  - Siqi Hong
AU  - Min Cheng
AU  - Jie Zhang
AU  - Tingsong Li
AU  - Li Jiang
PY  - 2022
JO  - Frontiers in Neurology
DO  - 10.3389/fneur.2022.909191
UR  - https://doi.org/10.3389/fneur.2022.909191
ER  - 

APA

Zhao, B., Liao, S., Zhong, X., Luo, Y., Hong, S., Cheng, M., Zhang, J., Li, T., & Jiang, L. (2022). Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study. Frontiers in Neurology. https://doi.org/10.3389/fneur.2022.909191

Source records